The Changing Faces of Acne | videos

An expert in dermatology shares his opinion on the multiple formulations of isotretinoin and the importance of generic vs brand compositions.

Dr Leon Kircik, discusses the novel treatment Clascoterone cream 1%, an androgen receptor agonist, and the utility of this treatment in the management of acne.

Leon Kircik, MD, shares his opinion on the role and use of treatment guidelines by healthcare practitioners in the management of their patients.

Christopher Bunick, MD, PhD, comments on the role isotretinoin plays in his practice and comments on further advancements in the management of this condition.

An expert in dermatology shares his opinion on oral versus topical acne treatment options and how to assess response to treatment.

Dr Christopher Bunick discusses the role the microbiome and sebum play in acne production and highlights the role Clascoterone cream 1% plays in targeting these agents.

Christopher Bunick, MD, PhD, provides an overview of acne vulgaris and the populations it impacts; highlighting that this is more than just an adolescent affliction and the role of sebum production.

An expert in dermatology reviews the differences in Isotretinoin and highlights how this treatment is both highly efficacious and safe when administered and monitored properly.

Dr Hilary Baldwin stresses the importance of defining severe acne and the utility of isotretinoin in this patient focusing on dosing and administration considerations.

Hilary Baldwin, MD, provides a recap of a panel discussion surrounding the optimal use of Clascoterone cream 1%, highlighting the ubiquity of this treatment.

An expert in dermatology reviews the differences in Isotretinoin and highlights utilization requirements in patients prescribed this treatment.

Dr James Q Del Rosso discusses the benefit of combination therapy in the management of acne and highlights the importance of combating acne scarring.

James Q Del Rosso, DO, shares his insight into some causes of acne and the utility of clascoterone cream 1% combat this condition in both male and female patient populations.

Dr Joshua Zeichner reviews the mechanism of action of Isotretinoin and highlights utilization requirements in patients prescribed this treatment.

Joshua Zeichner, MD, shares his insight into some causes of acne and the utility of clascoterone cream 1% combat this condition.

An expert in acne management provide his opinion on the differences between generic vs brand acne treatments and shares his thoughts on the utilization of available isotretinoin formulations.

Aaron Farberg, M.D discusses some common acne causes, highlighting the role of stress, diet, and androgen receptors for this condition.

Dr Aaron Farberg shares his recommendations for discussing acne treatment options with patients and provides insight on setting and managing patients’ goals and expectations.

Dr Leon Kircik, comments on the impact the multiple formulations of isotretinoin had on acne care; and highlights the efficacy differences between generic vs brand formulations.

Leon Kircik, M.D., discusses the indication of isotretinoin for use in patients suffering from acne, highlighting the difference between high and low dose administration needs.

An expert in acne management shares her insight into the patient characteristics a provider needs to consider when assessing the risk/benefit of a therapeutic agent for the management of acne.

Dr Zoe Diana Draelos discusses the role of ancillary skin care products in the management of acne and stresses the importance of setting patient expectations.

Zoe Diana Draelos, MD comments on the importance of tailoring acne treatments based on disease severity and the ability to target key acne pathogenesis factors.

Hilary Baldwin, M.D., shares her hopes for the future of acne treatment and provides her practice pearls from a panel discussion surrounding the management of patients suffering from acne.

An expert in acne management shares her insight on the current needs and the role of consensus guidelines in the management of patients suffering from acne.

Dr Hilary Baldwin discusses her treatment considerations and approach in the management of patients with mild to moderate acne, highlighting the benefit of combination therapy.

Hilary Baldwin, M.D., comments on the impact of the recent approval of clascoterone cream 1% in the topical acne armamentarium of patients suffering from acne.